Percutaneous Tubular Shunt Prosthesis for Cavopulmonary Bypass

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Children with single ventricle physiology (SVP) require invasive and traumatic surgical procedures like the Bi-directional Glenn operation and Fontan procedure, which are burdensome and have significant recuperation times, with no commercial alternatives for transcatheter interventions.

Innovation Solution

A percutaneously deliverable tubular prosthesis is used to create a shunt between the Superior Vena Cava and the main pulmonary artery, featuring distal and proximal sealing flanges with laterally extending projections to secure the prosthesis in place, allowing for a nonsurgical transcatheter approach.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical procedures (Glenn shunt or Fontan procedure) are performed to establish cavopulmonary bypass, then the required blood flow balance between systemic and pulmonary circulation is achieved, but the procedure becomes invasive and traumatic with significant recuperation time

Engineering Contradiction:
Improveblood flow balanceVSAvoidsurgical trauma
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical surgical intervention (open heart surgery with direct suturing and vascular anastomosis) with a transcatheter-based delivery system that uses a self-expanding or balloon-expandable tubular prosthesis. The prosthesis is delivered via catheter through the lumen, avoiding external incisions and direct surgical manipulation of vessels, thereby substituting traumatic mechanical surgery with a less invasive catheter-based mechanical system

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a tubular prosthesis as an intermediary device that establishes the cavopulmonary bypass connection without requiring direct surgical anastomosis between vessels. The prosthesis acts as a mediator that can be delivered through the catheter lumen and deployed to create the necessary blood flow pathway, avoiding direct contact between surgical instruments and the patient's vascular system

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If traditional surgical procedures are used for cavopulmonary anastomosis, then a functional shunt is created between vessels, but the procedure requires excessive burden and lifelong medication intake

Engineering Contradiction:
Improveshunt functionalityVSAvoidrecuperation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces the complex surgical procedure requiring multiple stages and lifelong medication with a single-stage transcatheter deployment of a self-expanding or balloon-expandable prosthesis. The prosthesis is delivered via catheter and deployed to immediately establish functional cavopulmonary bypass, eliminating the need for prolonged recuperation and lifelong medication that would be required after traditional surgical intervention

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent incorporates sealing flanges with laterally extending projections on the prosthesis that are pre-configured to engage with the vessel wall and prevent pull-through during deployment. This preliminary structural design ensures immediate secure attachment and sealing upon deployment, eliminating the need for post-procedure medication to prevent complications and reducing recuperation time

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If a tubular prosthesis is deployed through a catheter to create a shunt, then the surgical burden is reduced, but the prosthesis must be securely anchored to resist being pulled through the ostium

Engineering Contradiction:
Improvedelivery methodVSAvoidanchoring strength
Core Design Contradiction:
Ease of operationVSStrength

Solution Approach 1:

The patent adds a lateral dimension to the anchoring mechanism by incorporating laterally extending projections on the sealing flanges. These projections extend radially outward from the main body of the prosthesis in a direction perpendicular to the longitudinal axis, creating anchoring points that engage with the vessel wall in three-dimensional space. This dimensional addition provides resistance against longitudinal pull-through forces while maintaining the percutaneous delivery approach

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent employs asymmetric sealing flange designs where the flanges have different structures at their proximal and distal ends, with laterally extending projections positioned to provide differential anchoring. The asymmetric configuration allows the prosthesis to be securely anchored in one direction (resisting pull-through) while maintaining compliance and sealing in other directions, optimizing both ease of delivery and anchoring strength

Inventive Principle:
Principle #4Asymmetry

Data Source

PatentUS20250325268A1Percutaneous shunt devices and methods
Publication Date: 2025.10.23 TRANSMURAL SYSTEMS LLC
  • US20250325268A1 patent drawing
  • US20250325268A1 patent drawing
  • US20250325268A1 patent drawing

AI summary

The disclosure provides various embodiments of prostheses and delivery systems to permit an interventional cardiologist to create shunts between various blood vessels. Moreover, the disclosed shunts can be used to shunt between various hollow organs, as set forth in the present disclosure.